Insitro vs PubMed - AI Tool Comparison 2026
Data updated: (latest change to a listed tool; GateOnAI Scores are recomputed nightly)
Side-by-side comparison of Insitro and PubMed from GateOnAI catalogue data: pricing model, GateOnAI Score, inputs and outputs.
PubMed
Free AI-enhanced biomedical literature database
Category: Science
Pricing: Free
Best for: Science
Side-by-Side Comparison
| Feature | Insitro | PubMed |
|---|---|---|
| Pricing | Paid | Free |
| Category | Science | Science |
| Best For | Science | Science |
| GateOnAI Score | 54/100 | 79/100 |
| Website | Insitro | PubMed |
Frequently Asked Questions
What is Insitro?
Insitro builds a different kind of drug company that uses machine learning and large‑scale data to decode biology and create new medicines. It combines over 20 petabytes of automated cellular experiments with population‑scale genetics to construct Physical AI systems that identify causal drivers of human disease. Its Virtual Human™ platform, built on the world’s largest integrated multimodal corpus of clinical and cellular data, acts as a genetically anchored causal AI engine that maps disease onset, progression and resolution, pinpointing causal targets before candidate optimization. TherML, the company’s modality‑agnostic AI‑driven therapeutics design engine, matches the best‑fit modality—small molecules, oligonucleotides or complex biologics—to each target, shifting discovery from stochastic screening to predictive, adaptive engineering for faster, better molecule development. GateOnAI Score: 54/100.
What is PubMed?
PubMed® provides access to more than 40 million citations for biomedical literature drawn from MEDLINE, life‑science journals, and online books. The service includes citation details and may link to full‑text content hosted on PubMed Central or publisher websites. As an official U.S. government site (a .gov domain), PubMed ensures secure, encrypted connections via HTTPS. The platform regularly updates its resources, offering features such as a New & Noteworthy RSS feed for NLM Technical Bulletin news, revised article‑type filters reflecting MeSH changes, and annual baseline releases of MEDLINE citations with the latest MeSH terms. These updates help users stay current with evolving biomedical research and terminology. PubMed is intended for anyone needing comprehensive, authoritative biomedical citation data, including researchers, clinicians, and students seeking reliable literature references. GateOnAI Score: 79/100.
What is the difference between Insitro and PubMed?
Insitro is best for Science. PubMed is designed for Science. Insitro strengths: Online at our latest daily check. PubMed strengths: Listed as free to use; Online at our latest daily check.
Which is better: Insitro or PubMed?
GateOnAI rates Insitro 54/100 and PubMed 79/100. Insitro is tagged for Science. PubMed is tagged for Science. Choose Insitro if you need Online at our latest daily check. Choose PubMed if you need Listed as free to use.
Is Insitro free?
Insitro offers Paid pricing. See the website for current plans.
Is PubMed free?
PubMed offers Free pricing. Get started for free.
What are the pros and cons of Insitro vs PubMed?
Insitro pros: Online at our latest daily check. Main limitation: No free plan listed - check the vendor for a trial. PubMed pros: Listed as free to use; Online at our latest daily check. Main limitation: No limitations recorded on GateOnAI.